Physicians Realty Trust Aktie News

All of us could benefit from a little extra income every month, and many dividend investors look for passive income through dividend stocks.

Investors love dividend stocks, especially high-yield varieties, because they offer a significant income stream and have substantial total return potential.

Most dividend checks arrive only four times a year, which means investors who live off the income are forced to budget every three months.

Just when investors thought this time just might be different, volatility came back in the door. A few words from Federal Reserve Chair Jerome Powell and heavier-than-expected capital expenditure guidance from some of the key hyperscalers stopped the stock rally in its tracks.

AI-driven tech stocks dominate 2025 returns, leaving dividend and high-yield ETFs lagging due to limited AI exposure. REITs face mixed fortunes: ARE and DOC struggle with life science oversupply, while IVT, AMT, ADC, and VICI offer attractive dividend growth and value. My current buy list focuses on undervalued REITs and ETFs with strong dividend growth.

Healthpeak Properties gets a buy rating for my initial coverage, agreeing with today's Wall St. consensus. Positives include active lease growth, portfolio growth in a niche demand for clinical outpatient care and lab space, and national diversification. A nearly 7% dividend yield along with proven FFO and operating cash flow growth, modest D/E, and investment-grade rating, offsets the negative...

Healthpeak Properties is paying out a 6.5% dividend yield that was 151% covered by its FFO during the third quarter. The REIT saw third-quarter renewal cash-releasing spreads on its Outpatient Medical segment move up by 5.4%, with Lab advancing by 4.6%. DOC most recently issued debt at a low spread of just 75 basis points to the current U.S. 10-year Treasury yield, while trading on its lowest m...

Healthpeak Properties, Inc. (NYSE:DOC ) Q3 2025 Earnings Call October 24, 2025 10:00 AM EDT Company Participants Andrew Johns - Senior Vice President of Investor Relations Scott Brinker - President, CEO & Director Kelvin Moses - Chief Financial Officer Conference Call Participants Ronald Kamdem - Morgan Stanley, Research Division Nicholas Yulico - Scotiabank Global Banking and Markets, Research...